Get started
Author

P. David Charles

Observed name: P. Charles
OpenAlex ID: A5048869147
The 201 Trial: a placebo-controlled randomized phase 2 study of safety and tolerance of the c-Abl kinase inhibitor risvodetinib in untreated Parkinson’s disease
2026 · M. H. Werner, A. McGarry, et al. · Nature Aging · 6
PDF
List of Contributors
2011 · Ana P.L. Abdala, David H. Adams, et al. · Elsevier eBooks
DANGER
2003 · P. David Charles · Neurology Today
Works count: 3
Citation count: 6
H-index: 1
I10-index:
Year
Topic
Type